Phathom Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $57,584 | $49,504 | $39,503 | $28,519 |
Gross Profit | 49,937 | 43,314 | 34,465 | 24,795 |
EBITDA | 320,039 | -13,709 | -58,120 | -76,068 |
EBIT | 319,911 | -13,865 | -58,292 | -76,245 |
Net Income | 200,099 | -29,973 | -75,810 | -94,316 |
Net Change In Cash | 57,584 | 49,504 | 39,503 | 28,519 |
Free Cash Flow | -4,886 | -14,115 | -62,729 | -84,948 |
Cash | 129,972 | 135,156 | 149,569 | 212,315 |
Basic Shares | 72,918 | 73,396 | 72,466 | 71,969 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $175,110 | $55,252 | $682 | $0 |
Gross Profit | 152,511 | 47,279 | 515 | -620 |
EBITDA | 633 | -261,522 | -159,049 | -169,798 |
EBIT | 0 | -262,317 | -159,624 | -170,418 |
Net Income | -334,326 | -201,592 | -197,723 | |
Net Change In Cash | 175,110 | 55,252 | 682 | 0 |
Free Cash Flow | -166,775 | -266,905 | -139,214 | -147,571 |
Cash | 129,972 | 297,263 | 381,393 | 155,385 |
Basic Shares | 72,918 | 63,176 | 51,289 | 39,118 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.08 |
2025-09-30 | -$0.15 |
2025-06-30 | -$0.79 |
